Literature DB >> 2362194

Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine.

M A Hansen1, C Hassager, K Overgaard, U Marslew, B J Riis, C Christiansen.   

Abstract

We compared two methods of measuring spinal bone mineral content and density (BMC/BMD): conventional dual-photon absorptiometry (DPA) and a more recent method, dual-energy x-ray absorptiometry (DEXA). The clinical usefulness of both methods was compared in the measurement of BMC in the forearm. DEXA had a long-term in vivo precision of 1% which was significantly better than that of DPA. Changes in the distribution of fatty tissue influenced the accuracy of the two spinal methods in different ways. Forearm BMC discriminated between the bone mass of early and late postmenopausal women to the same degree as DPA and DEXA. The variability in the response to estrogen treatment and placebo was much lower with DEXA and forearm BMC than with DPA. We conclude that DEXA provides a fast and precise measurement of spinal BMC/BMD. The accuracy remains to be evaluated for in vivo studies.

Entities:  

Mesh:

Year:  1990        PMID: 2362194

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  28 in total

1.  Dual-energy X-ray absorptiometry in the lumbar spine, proximal femur and distal radius in children.

Authors:  H Tsukahara; M Sudo; M Umezaki; M Hiraoka; K Yamamoto; Y Ishii; S Haruki
Journal:  Pediatr Radiol       Date:  1992

2.  Measurements of bone mineral density of the proximal femur by two commercially available dual energy X-ray absorptiometric systems.

Authors:  O L Svendsen; U Marslew; C Hassager; C Christiansen
Journal:  Eur J Nucl Med       Date:  1992

3.  An evaluation of dual-energy X-ray absorptiometry and comparison with dual-photon absorptiometry.

Authors:  B Lees; J C Stevenson
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

4.  Potential risk factors for development of postmenopausal osteoporosis--examined over a 12-year period.

Authors:  M A Hansen; K Overgaard; B J Riis; C Christiansen
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

5.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

6.  Human growth hormone and growth hormone releasing hormone: a double-masked, placebo-controlled study of their effects on bone metabolism in elderly women.

Authors:  B Clemmesen; K Overgaard; B Riis; C Christiansen
Journal:  Osteoporos Int       Date:  1993-12       Impact factor: 4.507

7.  The effect of DXA scanning on clinical decision making by general practitioners: a randomized, prospective trial of direct access versus referral to a hospital consultant.

Authors:  V Dhillon; J Creiger; J Hannan; N Hurst; G Nuki
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

8.  Anteroposterior and lateral spinal DXA for the assessment of vertebral body strength: comparison with hip and forearm measurement.

Authors:  K Bjarnason; C Hassager; O L Svendsen; H Stang; C Christiansen
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

9.  Influence of patient's weight on dual-photon absorptiometry and dual-energy X-ray absorptiometry measurements of bone mineral density.

Authors:  P Martin; M Verhas; C Als; L Geerts; J Paternot; P Bergmann
Journal:  Osteoporos Int       Date:  1993-07       Impact factor: 4.507

10.  The impact of degenerative conditions in the spine on bone mineral density and fracture risk prediction.

Authors:  P von der Recke; M A Hansen; K Overgaard; C Christiansen
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.